文献速递冠心病

体重指数与急性冠脉综合征患者院内主要不良心脑血管事件的相关性

[The association between body mass index and in-hospital major adverse cardiovascular and cerebral events in patients with acute coronary syndrome].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2024-01-01

基于CCC项目多中心前瞻性队列,纳入71 681例18~80岁ACS住院患者,按入院BMI分为低体重、正常体重、超重和肥胖四组。低体重组院内MACCE发生率14.9%,高于正常体重组的9.5%;多因素回归显示低体重组MACCE风险高于正常体重组(OR=1.30,95%CI 1.13~1.49,P<0.001),超重和肥胖组与正常体重组差异无统计学意义。

要点

  • ACS患者中低体重(BMI<18.5 kg/m2)与院内MACCE风险升高相关。
  • 超重和肥胖组院内MACCE风险与正常体重组无统计学差异。
  • BMI可能作为评估ACS患者短期预后的指标。

核心结论

  • BMI低于正常的ACS患者院内MACCE发生风险高,BMI有可能成为评价ACS患者短期预后的一项指标。

研究设计与样本

  • 多中心前瞻性队列研究,数据来源于中国心血管疾病医疗质量改善(CCC)项目。
  • 入选2014年11月1日至2019年12月31日CCC项目中年龄18~80岁的ACS住院患者,共71 681例,年龄(63.4±14.7)岁,女性占26.5%(18 979/71 681)。
  • 按入院第1次测得的BMI分为低体重组(BMI<18.5 kg/m2,2 154例)、正常体重组(BMI 18.5~24.9 kg/m2,41 960例)、超重组(BMI 25.0~29.9 kg/m2,24 140例)和肥胖组(BMI≥30.0 kg/m2,3 427例)。
  • 主要结局为住院期间MACCE,包括全因死亡、再次心肌梗死、心力衰竭、心原性休克、心脏骤停和卒中;采用多因素logistic回归模型分析BMI与院内MACCE风险的关系。

主要发现

  • 低体重组、正常体重组、超重组和肥胖组的院内MACCE发生率分别为14.9%(322/2 154)、9.5%(3 997/41 960)、7.9%(1 908/24 140)和7.0%(240/3 427)(P<0.001)。
  • 多因素logistic回归显示,低体重组MACCE发生风险高于正常体重组(OR=1.30,95%CI 1.13~1.49,P<0.001)。
  • 超重组和肥胖组MACCE发生风险与正常体重组差异均无统计学意义(P均>0.05)。

临床怎么用

  • 对ACS住院患者应记录入院BMI,识别BMI<18.5 kg/m2的低体重患者为院内MACCE高风险人群。
  • 低体重可作为ACS患者短期预后评估的参考指标之一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To assess the association between body mass index (BMI) and major adverse cardiovascular and cerebrovascular events (MACCE) among patients with acute coronary syndrome (ACS). Methods: This was a multicenter prospective cohort study, which was based on the Improving Care for Cardiovascular Disease in China (CCC) project. The hospitalized patients with ACS aged between 18 and 80 years, registered in CCC project from November 1, 2014 to December 31, 2019 were included. The included patients were categorized into four groups based on their BMI at the time of admission: underweight (BMI<18.5 kg/m2), normal weight (BMI between 18.5 and 24.9 kg/m2), overweight (BMI between 25.0 and 29.9 kg/m2), and obese (BMI≥30.0 kg/m2). Multivariate logistic regression models was used to analyze the relationship between BMI and the risk of in-hospital MACCE. Results: A total of 71 681 ACS inpatients were included in the study. The age was (63.4±14.7) years, and 26.5% (18 979/71 681) were female. And the incidence of MACCE for the underweight, normal weight, overweight, and obese groups were 14.9% (322/2 154), 9.5% (3 997/41 960), 7.9% (1 908/24 140) and 7.0% (240/3 427), respectively (P<0.001). Multivariate logistic regression analysis showed a higher incidence of MACCE in the underweight group compared to the normal weight group (OR=1.30, 95%CI 1.13-1.49, P<0.001), while the overweight and obese groups exhibited no statistically significant difference in the incidence of MACCE compared to the normal weight group (both P>0.05). Conclusion: ACS patients with BMI below normal have a higher risk of in-hospital MACCE, suggesting that BMI may be an indicator for evaluating short-term prognosis in ACS patients. 目的: 了解体重指数(BMI)与急性冠脉综合征(ACS)患者院内主要不良心脑血管事件(MACCE)的相关性。 方法: 该研究是一项多中心前瞻性队列研究。研究数据来源于中国心血管疾病医疗质量改善(CCC)项目。入选2014年11月1日至2019年12月31日CCC项目中年龄介于18~80岁的ACS住院患者,按照入院第1次测得的BMI分为4组:低体重组(BMI<18.5 kg/m2)、正常体重组(BMI 18.5~24.9 kg/m2)、超重组(BMI 25.0~29.9 kg/m2)和肥胖组(BMI≥30.0 kg/m2)。主要结局为住院期间发生的MACCE,包括全因死亡、再次心肌梗死、心力衰竭、心原性休克、心脏骤停和卒中。采用多因素logistic回归模型分析BMI与院内MACCE发生风险的关系。 结果: 研究共纳入71 681例ACS住院患者,年龄(63.4±14.7)岁,女性占26.5%(18 979/71 681),低体重组、正常体重组、超重组和肥胖组分别有2 154、41 960、24 140和3 427例。低体重组、正常体重组、超重组和肥胖组的院内MACCE发生率分别为14.9%(322/2 154)、9.5%(3 997/41 960)、7.9%(1 908/24 140)和7.0%(240/3 427)(P<0.001)。多因素logistic回归分析结果显示,低体重组的MACCE发生风险高于正常体重组(OR=1.30,95%CI 1.13~1.49,P<0.001),超重组和肥胖组MACCE发生风险与正常体重组差异均无统计学意义(P均>0.05)。 结论: BMI低于正常的ACS患者院内MACCE发生风险高,BMI有可能成为评价ACS患者短期预后的一项指标。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhou, Zhu, Wang, et al. [The association between body mass index and in-hospital major adverse cardiovascular and cerebral events in patients with acute coronary syndrome]. Zhonghua Xin Xue Guan Bing Za Zhi. 2024. PMID: 38220454. doi:10.3760/cma.j.cn112148-20230915-00165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。